Searched for
SANOFI PFIZER
Over 250 medicines to cost more from January 1 in the U.S; is your critical drug in the list? Check hereMore than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning January 1, 2025.- Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
- France's Sanofi signs COVID-19 vaccine deal with NovavaxSanofi and Novavax partnered for a COVID-19 vaccine deal. Novavax will receive $1.2 billion in milestones. Sanofi will take an equity stake...
- Sanofi plans to split consumer health unit to narrow focusSanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a sep...
- Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
- Sanofi names Rodolfo Hrosz as India unit headHrosz will transition from being Sanofi’s general manager, Consumer Healthcare business in Brazil to his new role in India as soon as the a...
- Sanofi drops plans for messenger RNA vaccine against virusThe Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That...
- France's Sanofi to manufacture vaccines developed by rival Pfizer-BioNTechThe Germany-based BioNTech will initially produce the vaccines at Sanofi facilities in Frankfurt, starting in the summer, according to a Sa...
- Sanofi says its coronavirus vaccine won’t require supercoolingThe companies said they expect to supply up to 50 million vaccine doses globally in 2020, and up to 1.3 billion doses in 2021.
- EU talks with Pfizer, Sanofi, J&J on COVID-19 vaccines hit pricing, payment roadblocksThe bloc is in talks with at least six vaccine makers to acquire up front doses of potential shots against the novel coronavirus, officials...
- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- Sanofi plans mega US deal to counter sales dipSanofi-Aventis, France’s biggest drugmaker, is preparing a major acquisition in the US, according to five people with knowledge of the situ...
- Piramal Health stock on a seesaw rideA fresh round of acquisition talk took the Piramal Healthcare stock soaring in early trade on Wednesday, but it came off shortly after the ...
- Pharma cos shares extend gain on BSEShares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...
- More drug MNCs join the stake-hike bandwagonAfter the two leading pharma multinationals recently increased their stakes in their Indian units, people connected with the industry say t...
- MNC pharma cos in race for RFCL unitVirbac, Sanofi Aventis and Pfizer have evinced interest in buying animal healthcare unit of RFCL, the fine-chemical business owned by ICICI...
- Pfizer, Sanofi vie for Wockhardt biotechWockhardt may have to hive off its biotech business into a separate company to clear the way for another company to pick up stake.
- Reports: Pfizer, Wyeth said to be close to dealPfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open Monday.
- Plavix copies hit Sanofi-Aventis, net drops 12%Sanofi-aventis reported a 12% drop in third-quarter profit on Tuesday, citing the loss of top-selling blood thinner Plavix to generic compe...
- Schering-Plough, Sanofi set sights on Bristol-MyersBristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...
Load More
